Valuation: TransMedics Group, Inc.

Market Cap 2.38B 2.08B 1.91B 1.78B 3.38B 227B 3.43B 22.99B 8.91B 111B 8.94B 8.74B 383B P/E 2026 *
36.1x
P/E 2027 * 21x
Enterprise Value 2.41B 2.11B 1.94B 1.81B 3.42B 230B 3.48B 23.32B 9.04B 113B 9.06B 8.87B 388B EV / Sales 2026 *
3.29x
EV / Sales 2027 * 2.7x
Free-Float
96.57%
Yield 2026 *
-
Yield 2027 * -
1 day+1.49%
1 week-11.43%
Current month+3.67%
1 month+0.60%
3 months-31.62%
6 months-43.87%
Current year-43.39%
1 week 64.84
Extreme 64.8448
71.67
1 month 64.84
Extreme 64.8448
80.72
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 1998-07-31
Director of Finance/CFO 55 2024-12-01
Chief Operating Officer 43 2023-02-01
Director TitleAgeSince
Director/Board Member 57 1998-07-31
Chairman 81 2010-12-31
Director/Board Member 78 2016-01-31
Date Insider Type Main position Quantity % Market Cap.
06-14Fiscal year

Director

48,194 0.1414%
05-19Free

Chairman

2,922 0.0086%
05-19Free

Director

2,922 0.0086%
Change 5-day change 1-year change 3-year change Capi.($)
+1.49%-11.43%-46.07%-18.00% 2.38B
+0.64%+3.50%+22.37%+0.32% 195B
+0.23%+6.59%-21.20%+24.59% 151B
+2.17%+2.44%-2.26%-17.53% 140B
+4.83%+2.13%-56.44%-16.55% 67.09B
+2.59%+5.18%+22.53%+0.04% 54.34B
-0.33%+2.07%-25.57%-31.08% 44.64B
-0.85%-3.56%+8.31%+8.68% 36.91B
+0.31%+0.64%+7.78%+42.30% 37.24B
-0.14%+0.96%-13.87%-19.29% 29.82B
Average +1.23%+0.82%-10.44%-2.65% 75.79B
Weighted average by Cap. +1.51%+3.31%-3.69%+0.13%

Financials

2026 *2027 *
Net sales 734M 641M 589M 549M 1.04B 69.84B 1.06B 7.09B 2.75B 34.26B 2.75B 2.69B 118B 869M 759M 697M 650M 1.23B 82.72B 1.25B 8.39B 3.25B 40.57B 3.26B 3.19B 140B
Net income 75.93M 66.35M 60.92M 56.82M 108M 7.23B 110M 734M 284M 3.55B 285M 279M 12.22B 132M 115M 106M 98.53M 187M 12.54B 190M 1.27B 493M 6.15B 494M 484M 21.19B
Net Debt 33.99M 29.7M 27.28M 25.44M 48.22M 3.24B 49.03M 328M 127M 1.59B 128M 125M 5.47B -30.91M -27.01M -24.8M -23.13M -43.84M -2.94B -44.58M -299M -116M -1.44B -116M -114M -4.97B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
26-07-02 US$68.86 +1.49% 832,769
26-07-01 US$67.85 +2.15% 1,058,677
26-06-30 US$66.42 -1.29% 1,419,742
26-06-29 US$67.29 -1.68% 1,250,201
26-06-26 US$68.44 -11.97% 3,704,074
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
68.86USD
Average target price
117.33USD
Spread / Average Target
+70.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock